Clin2
NCT06983847Possibly a fitRecruiting

Long-term study of Vitamin-C Injektopas in vitamin C deficiency

Deficiency, Vitamin CChronic DiseaseAcute Disease

Part of Hormones & metabolism clinical trials.

This study observes patients with vitamin C deficiency who receive Vitamin-C Injektopas 7.5 g over time to understand how it is used and its effects. It may help if you have low vitamin C levels.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
18 years to 120 years
Study type
Observational

Who can take part

  • You have been diagnosed with vitamin C deficiency (low vitamin C in your body).
  • You are 18 years old or older.
  • You are not allergic to vitamin C or any ingredients in the injection.
  • You do not have certain health conditions like kidney stones (oxalate urolithiasis), iron overload diseases (like thalassemia, hemochromatosis, sideroblastic anemia), or recent red blood cell transfusion.
  • You do not have kidney problems (renal insufficiency) or a glucose-6-phosphate dehydrogenase deficiency.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07652346Recruiting
Vitamin C supplement study for healthy adults

This trial tests whether a vitamin C supplement affects vitamin C levels in healthy adults who have either low or normal levels. You'll take the supplement daily for a month and have blood drawn twice at a lab.

Carlsbad, California
NCT07184866Not yet recruiting
Vitamin C for kidney injury in severe liver failure with septic shock

This study tests whether giving high-dose vitamin C can help improve kidney function in people with severe liver failure, sudden kidney injury, and a serious infection with very low blood pressure. It's a randomized trial, meaning half the participants get vitamin C and half get a placebo, to see which group does better.

NCT07612345Not yet recruiting· Phase 1
High-dose vitamin C safety for pyruvate kinase or G6PD deficiency

This study tests whether high doses of vitamin C are safe for people with certain red blood cell conditions: pyruvate kinase deficiency or a specific type of G6PD deficiency (Class A). The goal is to see if vitamin C can be given safely to these patients.

Salt Lake City, Utah
NCT06794255Recruiting
Vitamin C for healthy aging in middle-aged adults

This study looks at whether vitamin C can help support healthy aging in middle-aged and older adults. It will compare taking vitamin C to a placebo (a dummy pill) to see if it improves overall health.

Nanchang, Jiangxi
NCT07121036Recruiting· Phase 1
High-dose vitamin C infusion for advanced solid tumors

This trial tests a special high-dose vitamin C infusion, given based on how your body processes it, for people with advanced solid tumors. It aims to see if this vitamin C therapy can be safely combined with your current or new chemotherapy to help control the cancer.

Wuhan, Hubei
NCT07388121Recruiting
Vitamin C and gut health in healthy adults

This trial tests whether taking vitamin C supplements changes the bacteria in your gut and how well your gut works. If you are a healthy adult, you may be able to join.

Glasgow

Hear when a new Chronic Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.